Schedule-dependent interaction between anticancer treatments

Science

Volumn 351, Issue 6278, 2016, Pages 1204-1208

  Chen, Sheng Hong ^a   Forrester, William ^b   Lahav, Galit ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CAMPTOTHECIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; DACTINOMYCIN; DOUBLE STRANDED DNA; DOXORUBICIN; DOXYCYCLINE; PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53; SMALL INTERFERING RNA; ZINOSTATIN; ANTINEOPLASTIC AGENT;

CANCER; CELLS AND CELL COMPONENTS; CYTOGENETICS; DISEASE TREATMENT; DNA; GENE; GENE EXPRESSION; INHIBITOR; TUMOR;

APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; MOLECULAR IMAGING; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; QUANTITATIVE STUDY; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; DNA DAMAGE; GENE SILENCING; GENETICS; MCF-7 CELL LINE; METABOLISM; NEOPLASMS; TIME FACTOR;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DNA DAMAGE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; MOLECULAR IMAGING; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84960847121     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aac5610     Document Type: Article

References (22)

1. M. J. Lee et al., Cell 149, 780-794 (2012).
2. S. W. Morton et al., Sci. Signal. 7, ra44 (2014).
3. M. Wade, Y.-C. Li, G. M. Wahl, Nat. Rev. Cancer 13, 83-96 (2013).
4. A. Gembarska et al., Nat. Med. 18, 1239-1247 (2012).
5. C. J. Brown, S. Lain, C. S. Verma, A. R. Fersht, D. P. Lane, Nat. Rev. Cancer 9, 862-873 (2009).
6. J. A. Barboza, T. Iwakuma, T. Terzian, A. K. El-Naggar, G. Lozano, Mol. Cancer Res. 6, 947-954 (2008).
7. F. Mancini et al., Int. J. Biochem. Cell Biol. 42, 1080-1083 (2010).
8. X. Wang, J. Wang, X. Jiang, J. Biol. Chem. 286, 23725-23734 (2011).
9. J. E. Purvis et al., Science 336, 1440-1444 (2012).
10. B. Graves et al., Proc. Natl. Acad. Sci. U.S.A. 109, 11788-11793 (2012).
11. D. Reed et al., J. Biol. Chem. 285, 10786-10796 (2010).
12. G. Lahav et al., Nat. Genet. 36, 147-150 (2004).
13. A. Loewer, E. Batchelor, G. Gaglia, G. Lahav, Cell 142, 89-100 (2010).
14. E. Batchelor, C. S. Mock, I. Bhan, A. Loewer, G. Lahav, Mol. Cell 30, 277-289 (2008).
15. H. Kawai et al., J. Biol. Chem. 278, 45946-45953 (2003).
16. G. Lahav, Adv. Exp. Med. Biol. 641, 28-38 (2008).
17. O. D. K. Maddocks et al., Nature 493, 542-546 (2013).
18. M. Behar, D. Barken, S. L. Werner, A. Hoffmann, Cell 155, 448-461 (2013).
19. P. Lito, N. Rosen, D. B. Solit, Nat. Med. 19, 1401-1409 (2013).
20. J. Bieler et al., Mol. Syst. Biol. 10, 739 (2014).
21. C. Feillet et al., Proc. Natl. Acad. Sci. U.S.A. 111, 9828-9833 (2014).
22. A. Sancar et al., FEBS Lett. 584, 2618-2625 (2010).